Importantly, a recent study by Shah and colleagues [11] has demonstrated that the intra-tumor genetic heterogeneity found in breast cancers may affect even known driver genetic aberrations, such as TP53 and PIK3CA somatic mutations. Here, TP53 is linked to breast carcinoma.